肺部康复与平衡训练,以减少慢性阻塞性肺病的跌倒:一项随机对照试验
Qiukui Hao1, Dina Brooks1,2,3,4,5, Cindy Ellerton2,3
1School of Rehabilitation Science, Faculty of Health Science, McMaster University, IAHS, 1400 Main St. W, Hamilton, ON, L8S 1C7, Canada.
BMC pulmonary medicine
|August 24, 2024
概括
在肺部康复中添加平衡训练并没有减少慢性阻塞性肺病 (COPD) 的成年人的跌倒. 这项研究发现,在12个月内,小组之间的跌倒发生率没有显著差异.
科学领域:
- 肺部医学 肺部医学
- 老年病的医生 老年病的医生
- 康复科学 康复科学 康复科学
背景情况:
- 患有慢性阻塞性肺病 (COPD) 的成年人表现出比健康个体更差的平衡.
- 平衡训练已经显示出在COPD患者中改善平衡的潜力.
- 高跌倒风险是COPD患者的一个重要问题.
研究的目的:
- 研究将平衡训练纳入肺部康复 (PR) 计划的影响.
- 评估这种综合方法在12个月的随访期间对跌倒的发生率的影响.
- 评估COPD成年人的结果,确定患有高跌倒风险.
主要方法:
- 进行了一项前性的,国际性的,多中心的随机对照试验.
- 具有高跌倒风险的COPD参与者被随机分配 (1:1) 接受通常的PR加平衡训练或通常的PR单独.
- 主要结果,跌倒发生率,用每月的跌倒日记在12个月内进行测量;统计分析采用负二项式回归或反复事件模型.
主要成果:
- 在258名注册参与者中,有178人被纳入初级分析.
- 45%的干预组和38%的对照组至少有一次跌倒 (p=0.34).
- 平均跌倒发生率在各组之间是可比的 (每100个人年有128次跌倒),没有统计学上显著的差异.
结论:
- 与单独PR相比,结合平衡训练的肺部康复并没有显著降低跌倒的发生率.
- 研究结果表明,这种联合干预可能无法在12个月的时间内有效地预防高风险COPD患者的跌倒.
- 可能需要进一步的研究来探索替代或优化策略,以防止在这个人群中跌倒.
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Chronic Obstructive Pulmonary Disease-V: Nursing Management
3.7K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
3.7K
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Pulmonary Function Tests
312
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
312
COPD: Management Using Bronchodilators and Corticosteroids
190
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
190
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
189
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
189


